Analyst Ratings
Upgrades, downgrades, and price-target changes from Wall Street firms.
Freedom Capital Markets Reiterates Buy Rating on FWRG
Freedom Capital Markets reaffirms its buy rating on FWRG, setting a $17 price target.
Freedom Capital Markets Reiterates Buy Rating for El Pollo Loco
Freedom Capital Markets keeps its 'buy' rating on El Pollo Loco with a $22 price target.
Baird Reiterates Buy Rating on Abbott Laboratories
Baird reaffirmed its buy rating on Abbott Laboratories, setting a $121 price target.
Freedom Capital Markets Reiterates Buy Rating on Inspire Medical Systems
Freedom Capital Markets maintains its positive outlook on Inspire Medical Systems with a $62 price target.
Freedom Capital Markets Reiterates Buy Rating on HTFL
Freedom Capital Markets reiterated its buy rating on HTFL, setting a price target of $37.
Raymond James Reiterates Buy Rating for Amplitude, Inc.
Raymond James maintains its buy rating on Amplitude, Inc. with a $10 target price.
B. Riley Securities Reiterates Buy Rating for Starz Entertainment
B. Riley Securities reaffirmed its buy rating for Starz Entertainment with a $45 price target.
Roth Capital Upgrades TALO to Buy with Price Target at $17
Roth Capital's analyst Leo Mariani upgrades TALO to a buy with a new price target of $17.
Baird Reiterates Buy Rating on Innio N.V. with $50 Target
Baird analyst Ben Kallo maintains a buy rating on Innio N.V., setting a $50 price target.
Baird Reiterates Buy Rating for Applied Aerospace & Defense, Inc. (AADX)
Baird reaffirms its buy rating on Applied Aerospace & Defense with a $30 target.
BMO Capital Reiterates Buy Rating for Sunshine Silver Mining
BMO Capital maintains a buy rating on Sunshine Silver Mining & Refining with a $16.5 price target.
HC Wainwright Upgrades Prime Medicine to 'Buy' with $8 Target
HC Wainwright & Co. raised its price target on Prime Medicine, Inc. to $8.00 and upgraded the stock to 'buy'.
BTIG Reiterates Buy Rating for Liftoff Mobile, Inc. (LFTO)
BTIG maintains a buy rating on Liftoff Mobile with a $35 target.
HC Wainwright Reiterates Buy Rating on Monopar Therapeutics
HC Wainwright maintains its buy rating for Monopar Therapeutics with a $105 price target.
Needham Reiterates Buy Rating on Quantinuum Inc. (QNT)
Needham has reiterated its buy rating on Quantinuum Inc., setting a price target of $100.
B of A Securities Reiterates Buy Rating for Quantinuum Inc. (QNT)
B of A Securities maintains a buy rating for Quantinuum Inc. with a $100 price target.
B of A Securities Downgrades Definitive Healthcare Corp. to 'Sell'
B of A Securities sets a new price target of $0.70 for Definitive Healthcare, downgrading it to 'sell'.
B of A Securities Reiterates Buy Rating for Applied Aerospace & Defense
B of A Securities maintains a buy rating on Applied Aerospace & Defense with a $24 price target.
B of A Securities Reiterates Buy Rating on Innio N.V.
B of A Securities reaffirms its buy rating for Innio N.V., setting a price target of $46.
B of A Securities Downgrades Amphastar Pharmaceuticals to 'Sell'
Amphastar Pharmaceuticals received a 'sell' rating from B of A Securities with a $20 price target.
Needham Reiterates Buy Rating for Liftoff Mobile, Inc.
Needham maintains its buy rating on Liftoff Mobile, Inc. with a $42 price target.
Evercore ISI Reiterates Buy Rating on Quantinuum Inc.
Evercore ISI reaffirms its buy rating for Quantinuum Inc. with a $98 target.
Goldman Sachs Reiterates Buy Rating on Liftoff Mobile, Inc.
Goldman Sachs maintains a buy rating for Liftoff Mobile, Inc. with a $40 price target.
Goldman Sachs Reaffirms Buy Rating for Innio N.V.
Goldman Sachs maintains its buy rating on Innio N.V., setting a price target of $42.